FDA Inspection 1321128 — BioLife Plasma Services, L.P.
The FDA completed an inspection of BioLife Plasma Services, L.P. on Jun 8, 2026 in Glendale, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 8, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Glendale, AZ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12202 | 21 CFR 606.170(a) | Adverse Reaction - Investigations |
| 57 | 21 CFR 606.60(a) | Maintain and clean equipment |
| 88 | 21 CFR 606.100(b)(9) | Written methods for investigating adverse reactions |